Abstract 12793: Warfarin Use Prompting Significant Intervention in the Emergency Department: Acute Hemorrhage and Bleeding Concerns
Charles V. Pollack, John Fanikos(General Department of Preventive Medicine), G. Fermann, Gregory Fiore, Alex Frost, Steven H. Silber(NewYork–Presbyterian Brooklyn Methodist Hospital), W. Frank Peacock(Hennepin Healthcare Research Institute), Babak S. Jahromi, James D. Douketis(McMaster University), Todd C. Villines(University of Virginia Health System), Richard A. Bernstein(Northwestern University), Geno Merli
Circulation
November 6, 2018
Cited by 0
Related Papers
Cryptogenic Stroke and Underlying Atrial Fibrillation
|New England Journal of Medicine|2014|2.2k
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
|New England Journal of Medicine|2017|1.1k
Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
|Circulation|2009|1k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study
|The Lancet Neurology|2012|775